Work

Efficacy and Safety of Odronextamab in Rare Subtypes of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL): Data from a Dedicated Cohort of Other B-NHLs in the ELM-2 Study

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-200150

Authors: Emmanuel Bachy, Tae Min Kim, Shang-Ju Wu, Jan Walewski, Jingxian Cai, Nickolas Sophos, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, H. Miles Prince

Institutions: Hospices Civils de Lyon, Seoul National University Hospital, National Taiwan University Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Regeneron (United States), The University of Melbourne

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039672

Cites:

Cited by: 1

Related to: 10